These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2090772)

  • 1. 5-Fluorouracil and recombinant alpha interferon-2a in the treatment of advanced colorectal carcinoma: a dose optimization study.
    Palmeri S; Gebbia V; Rausa L
    J Chemother; 1990 Oct; 2(5):327-30. PubMed ID: 2090772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma.
    Wadler S; Goldman M; Lyver A; Wiernik PH
    Cancer Res; 1990 Apr; 50(7):2056-9. PubMed ID: 2317795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluorouracil plus interferon alpha-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: a multicentric randomized study.
    Palmeri S; Meli M; Danova M; Bernardo G; Leonardi V; Dastoli G; Rausa L; Russo A; Filippelli G; Palmieri G; Russo A; Della Vittoria Scarpati M; Lo Russo V; Di Lauro L; Colucci G; Bruni G; Piazzi M; Gebbia N; Spada S
    J Cancer Res Clin Oncol; 1998; 124(3-4):191-8. PubMed ID: 9619746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.
    Wadler S; Schwartz EL; Goldman M; Lyver A; Rader M; Zimmerman M; Itri L; Weinberg V; Wiernik PH
    J Clin Oncol; 1989 Dec; 7(12):1769-75. PubMed ID: 2585018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorouracil and recombinant interferon alfa-2a in advanced gastrointestinal neoplasms.
    Pazdur R
    Br J Haematol; 1991 Oct; 79 Suppl 1():56-9. PubMed ID: 1931711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991.
    Wadler S; Atkins M; Karp D; Neuberg D; Haynes H; Dutcher JP
    Cancer J Sci Am; 1998; 4(4):261-8. PubMed ID: 9689985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of high-dose infusional hydroxyurea, high-dose infusional 5-fluorouracil and recombinant interferon-alpha-2a in patients with advanced malignancies.
    Wadler S; Haynes H; Schechner R; Rozenblit A; Wiernik PH
    Invest New Drugs; 1996; 13(4):315-20. PubMed ID: 8824349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.
    Pazdur R; Ajani JA; Patt YZ; Winn R; Jackson D; Shepard B; DuBrow R; Campos L; Quaraishi M; Faintuch J
    J Clin Oncol; 1990 Dec; 8(12):2027-31. PubMed ID: 2230894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferon.
    Wadler S; Fell S; Haynes H; Katz HJ; Rozenblit A; Kaleya R; Wiernik PH
    Cancer; 1993 Mar; 71(5):1726-30. PubMed ID: 8448736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    Tournigand C; Louvet C; de Gramont A; Lucchi E; Seitz JF; Mal F; Raymond E; Cady J; Carola E; Krulik M
    Cancer; 1997 Mar; 79(6):1094-9. PubMed ID: 9070485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.
    Greco FA; Figlin R; York M; Einhorn L; Schilsky R; Marshall EM; Buys SS; Froimtchuk MJ; Schuller J; Schuchter L; Buyse M; Ritter L; Man A; Yap AK
    J Clin Oncol; 1996 Oct; 14(10):2674-81. PubMed ID: 8874326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinoma.
    Wadler S; Wiernik PH
    Semin Oncol; 1990 Feb; 17(1 Suppl 1):16-21; discussion 38-41. PubMed ID: 2405491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A Multicenter Phase II study.
    Punt CJ; Burghouts JT; Croles JJ; van Liessum PA; de Mulder PH; Kamm Y
    Cancer; 1993 Oct; 72(7):2107-11. PubMed ID: 8374869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.
    J Clin Oncol; 1995 Apr; 13(4):921-8. PubMed ID: 7707120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma.
    Grem JL; Jordan E; Robson ME; Binder RA; Hamilton JM; Steinberg SM; Arbuck SG; Beveridge RA; Kales AN; Miller JA
    J Clin Oncol; 1993 Sep; 11(9):1737-45. PubMed ID: 8355041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity.
    Kemeny N; Younes A; Seiter K; Kelsen D; Sammarco P; Adams L; Derby S; Murray P; Houston C
    Cancer; 1990 Dec; 66(12):2470-5. PubMed ID: 2249187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double 5-fluorouracil modulation with folinic acid and recombinant alpha-2B-interferon. A phase I-II study in metastatic colorectal cancer patients.
    Brunetti I; Falcone A; Bertuccelli M; Cianci C; Ricci S; Conte PF
    Am J Clin Oncol; 1994 Jun; 17(3):210-4. PubMed ID: 8192103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: the Memorial Sloan-Kettering experience.
    Kemeny N; Younes A
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):171-5. PubMed ID: 1557642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.
    Grem JL; McAtee N; Murphy RF; Balis FM; Steinberg SM; Hamilton JM; Sorensen JM; Sartor O; Kramer BS; Goldstein LJ
    J Clin Oncol; 1991 Oct; 9(10):1811-20. PubMed ID: 1919632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.